How to make poison cough syrups

Published Date: 14 Mar 2023

According to market research firm Euromonitor, the global children's cough, cold and allergy products market in 2022 is worth $2.5 billion.

Read Full News

Latest News

Aprepitant Eases Cannabinoid Hyperemesis Syndrome in Teens

Hospitalized adolescents had a shorter stay and speedier symptom resolution with this adjunctive therapy.

Taylor Farms Recalls Salsa, Guacamole on Salmonella Outbreak, Intensifying Food-safety Fears

Taylor Farms is recalling prepared foods containing jalapenos from retailers including Walmart and Whole Foods in several states over potential salmonella contamination, the...

Distinguish Support Gaps From Caregiver Neglect, Docs Urged

Too often, clinicians add medications, appointments, and treatments without considering the cumulative burden has become unmanageable.

Hearing Screening For Preemies May Predict Cognition

Infants born extremely premature who do not pass newborn hearing screening assessments show lower scores on language and cognitive assessments at age 2.

Adults Born Very Preterm Show Distinct Functioning Profiles

Adults born very preterm or with very low birth weight show varied functioning profiles in adulthood, with a higher childhood intelligence quotient associated with positive functioning in adulthood.

Milk, Breastfeeding, and Teeth: What the Evidence Shows

Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

Hospitalized adolescents had a shorter stay and speedier symptom resolution with this adjunctive therapy.

Taylor Farms is recalling prepared foods containing jalapenos from retailers including Walmart and Whole Foods in several states over potential salmonella contamination, the...

Too often, clinicians add medications, appointments, and treatments without considering the cumulative burden has become unmanageable.

Infants born extremely premature who do not pass newborn hearing screening assessments show lower scores on language and cognitive assessments at age 2.

Adults born very preterm or with very low birth weight show varied functioning profiles in adulthood, with a higher childhood intelligence quotient associated with positive functioning in adulthood.

Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.

News All Time

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: Individualizing Prophylaxis

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Advancing Pediatric Hemophilia Care in the Non-Factor Era: From Factor Replacement to Rebalancing Therapies

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Newborn Girls Appear Less Likely to Get Vitamin K, Hepatitis B Shots

Relationship stronger for vitamin K; may be tied to circumcision

AAP Disputes Kennedy's Claim That Vaccine Panel Can't Meet Ahead of Flu Season

The federal government can "restore a lawful ACIP" and meet "at any time," AAP president says

RFK Jr. Goes After Journal That Removed Vaccine Study

"The paper's title tells you it shouldn't be published," said vaccine researcher Paul Offit

Outbreak Kills Over 200; ACIP Investigation Launched; Hackers Demand $75M From Novo

Health news and commentary gathered by MedPage Today staff

Over 770,000 Kids No Longer Receiving SNAP Benefits After Trump Changes Food Program

Arizona has seen the nation's largest percentage decline in SNAP participants

Generic Single-Dose Flu Antiviral Gets FDA's Blessing

Studies have shown baloxavir to be a standout among antivirals commonly used for influenza

Utah Marks a Year of Battling Measles, With No Clear End in Sight

Outbreaks will likely affect whether the U.S. can keep its measles-free designation

The Knicks Just Gave Us a Teaching Moment. Let's Not Waste It.

This historic win offers valuable lessons for young people's mental health

Shorter TB Regimen Matched Standard Care in Rifampicin-Resistant Disease

Protocol can be used in children and pregnant women

The Truth About 'Looksmaxxing'

Dr. Mike addresses the online epidemic affecting teen boys

New Charter Unveiled for CDC's Influential Vaccine Committee

Changes to rules governing ACIP could inject more politicization, experts warn

'Tiniest Penis' Fundraiser; Flu Vaccine Maker Investigated; FDA Rejects Gout Drug

Health news and commentary gathered by MedPage Today staff

Efforts to End School Vaccine Mandates Hit a Wall in Florida

The outcome could offer insights into such efforts' chances in other states

Recommended News For You

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Older Adults With Advanced Cancer Prioritize Quality of Life

FDA approves rivanetin as the first-line treatment for lung cancer.

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Timely ‘Nudges’ Help Spur Talks on Patient Care Goals

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

The Benefits and Risks of Thrombolytics: A Comprehensive Guide  

Comprehensive Updates in Hematology and Quality Improvement 

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies 

Rehabilitation of Physical Endurance Following Prolonged Cytopenic States 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

3.

It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.

4.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

5.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

1.

Emerging Advances in Hematology and Quality Improvement

2.

Practical Breakthroughs in Oncology Across Clinical Settings

3.

Nuclear Medicine's Role in Battling Women's Cancers

4.

Genetic Screening: A Game Changer in Cancer Prevention

5.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part VII

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

3.

Signs and Symptoms of Leukemia

4.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot